Brown & Brown, Inc. (BRO) SEC Filings & Earnings Calls
EquiReason read 17 Brown & Brown, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-10-22 — Director Bronislaw E. Masojada resigns from board and committees due to election as Lord Mayor of London; no disagreement with company..
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 24.4B
- P/E TTM
- 23.0
- Dividend yield
- 0.9%
- 52-week
- —
- Next earnings
- 26 Oct, in 2 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
22 Oct 20268-K · 5.02Director Bronislaw E. Masojada resigns from board and committees due to election as Lord Mayor of London; no disagreement with company.open
Risks flagged
Loss of a director with potential governance experience, but no operational impact expected.
“Resignation due to external obligations, not company-related issues.”
10 Aug 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)open
Risks flagged
Loss of a key executive in the Retail Segment could impact operations, though transition period mitigates immediate risk.
“Mr. Brown’s voluntary resignation for good reason from the Company, effective on August 10, 2026.” · word for word
27 Jul 20268-K · 2.02Total revenues $1.70B (+30% y/y); Organic Revenue growth % -0.7; Organic Revenue with Contingents growth % 0.7earningsopen
Figures in the filing · each found in the filing text
| Total revenues · Q2-2026 | $1.70B | +30% y/y |
| Organic Revenue growth % · Q2-2026 | -0.7% | |
| Organic Revenue with Contingents growth % · Q2-2026 | 0.7% | |
| Income Before Income Taxes Margin · Q2-2026 | 22.9% | |
| EBITDAC Margin - Adjusted · Q2-2026 | 35.7% | |
| Diluted Net Income Per Share - Adjusted · Q2-2026 | $1.07 | +4% y/y |
| Net income attributable to the Company · Q2-2026 | $288M | +25% y/y |
Risks flagged
Organic revenue decline signals potential competitive or market share pressure in core commissions and fees.
“Organic Revenue decreasing 0.7%” · word for word
Margin compression due to acquisition-related costs and amortization may persist.
“Income Before Income Taxes Margin 22.9% vs 24.2% prior year; EBITDAC Margin - Adjusted 35.7% vs 36.7%”
27 Jul 202610-QBrown & Brown reported Q2 2026 total revenue growth of 30.4% YoY, but organic revenue declined 0.7% due to slowing rate increases and rate decreases for certain lines of coverage.earningsopen
Figures in the filing · each found in the filing text
| Total revenues · Q2-2026 | $1.68B | +30% y/y |
| Net income attributable to the Company · Q2-2026 | $288M | +25% y/y |
| EBITDAC - Adjusted · Q2-2026 | $598M | +27% y/y |
| EBITDAC Margin - Adjusted · Q2-2026 | 35.7% | |
| Organic Revenue growth rate · Q2-2026 | -0.7% | |
| Organic Revenue with Contingents growth rate · Q2-2026 | 0.7% | |
| Core commissions and fees · Q2-2026 | $1.57B | +30% y/y |
| Profit-sharing contingent commissions · Q2-2026 | $85M | +89% y/y |
| Investment and other income · Q2-2026 | $22M | -39% y/y |
| Income before income taxes · Q2-2026 | $383M | +23% y/y |
Risks flagged
Organic Revenue Decline
“Our consolidated Organic Revenue decreased by 0.7% and our Organic Revenue with Contingents growth rate was 0.7%.” · word for word
Specialty Distribution Segment Weakness
“The Organic Revenue with Contingents decline was driven by: (i) increased Contingents; (ii) net new and retained business; and (iii) exposure unit expansion; which were more than offset by (iv) declining rates on catastrophe ("CAT") property.” · word for word
High Leverage from Acquisition Debt
“Total debt at June 30, 2026 was $7,759 million net of unamortized discount and debt issuance costs, which was an increase of $146 million compared to December 31, 2025.” · word for word
Litigation-Related Impact on Revenue
“an offsetting decrease of $18 million related to the Litigation-Related Impact” · word for word
5 Jun 20268-K · 1.01, 2.03Brown & Brown amended credit agreement increasing revolver from $800M to $1.25B, added $250M Term A-1 and $250M Term A-2 loans, extending maturities to 2029/2031.open
Figures in the filing · each found in the filing text
| Revolving Credit Facility amount · 2026-06-05 | $1.25B | |
| Term A-1 Loan Facility amount · 2026-06-05 | $250M | |
| Term A-2 Loan Facility amount · 2026-06-05 | $250M | |
| Outstanding borrowings · 2026-06-05 | $825M |
Risks flagged
Increased debt could lead to higher interest expense and leverage, though capacity is ample.
“$825 million outstanding; $1.75 billion total capacity”
7 May 20268-K · 5.02, 5.07Shares outstanding 339,559,191; Shares voted 306,507,079open
Figures in the filing · each found in the filing text
| Shares outstanding · 2026-03-02 | 339,559,191 | |
| Shares voted · 2026-05-06 | 306,507,079 |
Risks flagged
Potential dilution from additional shares authorized under stock plan.
“increase the number of shares available for issuance under the SIP by 6,900,000 shares” · word for word
27 Apr 20268-K · 2.02Total revenues $1.90B (+35% y/y); Diluted Net Income Per Share - Adjusted $1.39 (+8% y/y); EBITDAC Margin - Adjusted 38.5earningsopen
Figures in the filing · each found in the filing text
| Total revenues · Q1-2026 | $1.90B | +35% y/y |
| Diluted Net Income Per Share - Adjusted · Q1-2026 | $1.39 | +8% y/y |
| EBITDAC Margin - Adjusted · Q1-2026 | 38.5% | |
| Organic Revenue growth % · Q1-2026 | 0.0% | |
| Organic Revenue with Contingents growth % · Q1-2026 | 2.2% | |
| Net income attributable to the Company · Q1-2026 | $426M | +29% y/y |
| Diluted net income per share · Q1-2026 | $1.06 | -8% y/y |
| Income before income taxes · Q1-2026 | $533M | +25% y/y |
| Quarterly dividend per share · Q1-2026 | $0.17 |
Risks flagged
Organic revenue flat indicates potential market share or pricing pressure.
“Organic Revenue growth 0.0%”
Diluted GAAP EPS declined 7.8% due to higher amortization and acquisition costs.
“Diluted net income per share of $1.06, a decrease of 7.8%” · word for word
27 Apr 202610-QTotal revenues $1.90B (+35% y/y); Core commissions and fees $1.78B (+33% y/y); Profit-sharing contingent commissions $97M (+126% y/y)open
Figures in the filing · each found in the filing text
| Total revenues · Q1-2026 | $1.90B | +35% y/y |
| Core commissions and fees · Q1-2026 | $1.78B | +33% y/y |
| Profit-sharing contingent commissions · Q1-2026 | $97M | +126% y/y |
| Income before income taxes · Q1-2026 | $533M | +25% y/y |
| Net income attributable to the Company · Q1-2026 | $426M | +29% y/y |
| EBITDAC - Adjusted · Q1-2026 | $731M | +37% y/y |
| EBITDAC Margin - Adjusted · Q1-2026 | 38.5% | |
| Organic Revenue growth rate · Q1-2026 | 0.0% | |
| Organic Revenue with Contingents growth rate · Q1-2026 | 2.2% | |
| Operating cash flow · Q1-2026 | $262M | +23% y/y |
Risks flagged
Organic Revenue Deceleration
“Our consolidated Organic Revenue growth rate was flat and our Organic Revenue with Contingents growth rate was 2.2%.” · word for word
Specialty Distribution Organic Revenue Decline
“The Specialty Distribution segment's total commissions and fees increased by 40.7%, with Organic Revenue decreasing 2.0%” · word for word
Acquisition Integration Costs
“Other operating expenses for the first quarter of 2026 increased $103 million, or 55.4%, from the same period of 2025. This change includes: ... $26 million of Acquisition/Integration Costs associated with the Transaction” · word for word
24 Mar 2026DEF 14ATotal Revenues $5.90B (+23% y/y); Net Income Attributable to Company $1.10B (+10% y/y); Diluted Earnings Per Share $3.16 (-9% y/y)open
Figures in the filing · each found in the filing text
| Total Revenues · FY2025 | $5.90B | +23% y/y |
| Net Income Attributable to Company · FY2025 | $1.10B | +10% y/y |
| Diluted Earnings Per Share · FY2025 | $3.16 | -9% y/y |
| Net Cash Provided by Operating Activities · FY2025 | $1.50B | +25% y/y |
| Adjusted EBITDAC Margin · FY2025 | 36.0% | |
| Organic Revenue Growth · FY2025 | 2.8% | |
| Total Commissions and Fees Growth · FY2025 | 22.5% | |
| Income Before Income Taxes Margin · FY2025 | 23.2% |
Risks flagged
Organic growth deceleration
“Company Organic Revenue growth 2.8% 10.4%”
Integration risk from large acquisition
“Our acquisition of Accession, the ninth largest privately held insurance brokerage in the United States, was the largest in Brown & Brown's history, adding more than 5,500 talented teammates” · word for word
Key person concentration
“The ownership of our shares is highly concentrated, which could cause or exacerbate volatility in our share price as well as have significant influence over us.”
4 Mar 20268-K · 5.02Organic revenue growth target weight 40; adjusted EBITDAC margin target weight 40; personal objectives target weight 20open
Figures in the filing · each found in the filing text
| organic revenue growth target weight · FY2026 | 40.0% | |
| adjusted EBITDAC margin target weight · FY2026 | 40.0% | |
| personal objectives target weight · FY2026 | 20.0% | |
| target cash incentive - J. Powell Brown · FY2026 | $6M | |
| target cash incentive - R. Andrew Watts · FY2026 | $1M | |
| target cash incentive - J. Scott Penny · FY2026 | $1M | |
| target cash incentive - Chris L. Walker · FY2026 | $1M | |
| PSA grant - J. Powell Brown · FY2026 | $10M | |
| PSA grant - R. Andrew Watts · FY2026 | $5M | |
| PSA grant - J. Scott Penny · FY2026 | $3M |
Risks flagged
No material risks identified; routine compensation plan adoption.
“No disagreements or operational issues cited.”
12 Feb 202610-KTotal Debt $7.61B; Employees 22,888; Number of Acquisitions 43open
Figures in the filing · each found in the filing text
| Total Debt · 2025-12-31 | $7.61B | |
| Employees · 2025-12-31 | 22,888 | |
| Number of Acquisitions · FY2025 | 43 | |
| Teammate Stock Purchase Plan Participation (U.S.) · FY2025 | 60.0% |
Risks flagged
Increased Debt from Accession Acquisition
“As of December 31, 2025, our total debt was $7,613 million. We financed the purchase price of the Transaction with the net proceeds of certain securities offerings and cash on hand.” · word for word
Integration Risk from Accession Acquisition
“We may fail to realize all of the anticipated benefits of the Transaction... The full benefits of the Transaction... may not be realized as expected or may not be achieved within the anticipated time frame, or at all.” · word for word
Underwriting Risk from Captive Insurance Companies
“Accession’s ownership of one or more captive insurance companies subjects us to underwriting risk through such ownership and/or participation” · word for word
Litigation Related to Oxford Risk Management Group
“We cannot predict the ultimate outcome of the litigation pending against Accession’s subsidiary, Oxford Risk Management Group LLC” · word for word
26 Jan 20268-K · 2.02Total Revenues $1.61B (+36% y/y); Diluted Net Income Per Share - Adjusted $0.93 (+8% y/y); EBITDAC - Adjusted $529M (+36% y/y)earningsopen
Figures in the filing · each found in the filing text
| Total Revenues · Q4-2025 | $1.61B | +36% y/y |
| Diluted Net Income Per Share - Adjusted · Q4-2025 | $0.93 | +8% y/y |
| EBITDAC - Adjusted · Q4-2025 | $529M | +36% y/y |
| Organic Revenue · Q4-2025 | $1.08B | -3% y/y |
| Net Income Attributable to Company · Q4-2025 | $264M | +26% y/y |
Risks flagged
Organic revenue decline in Q4 may indicate underlying market softness or integration challenges; high acquisition-related amortization and integration costs.
“Organic Revenue decreasing 2.8% in Q4; Acquisition/Integration Costs of $27 million in Q4.”
28 Oct 202510-QBrown & Brown reported Q3 2025 results with total revenue growth of 35.4% YoY driven by the Accession acquisition, but organic revenue growth slowed to 3.5% from 9.5% a year ago, and net income declined 3% due to acquisition-related costs.earningsopen
Figures in the filing · each found in the filing text
| Total revenues · Q3-2025 | $1.61B | +35% y/y |
| Net income attributable to the Company · Q3-2025 | $227M | -3% y/y |
| Organic Revenue growth rate · Q3-2025 | 3.5% | |
| EBITDAC Margin - Adjusted · Q3-2025 | 36.6% | |
| Core commissions and fees · Q3-2025 | $1.48B | +31% y/y |
| Profit-sharing contingent commissions · Q3-2025 | $73M | +170% y/y |
| Income before income taxes · Q3-2025 | $311M | -2% y/y |
| EBITDAC - Adjusted · Q3-2025 | $587M | +42% y/y |
| Operating cash flow · 9M-2025 | $1.01B | +24% y/y |
| Total debt · 2025-09-30 | $7.73B |
Risks flagged
Integration risk from large acquisition
“WE MAY FAIL TO REALIZE ALL OF THE ANTICIPATED BENEFITS OF THE TRANSACTION (INCLUDING USE OF ACCESSION’S DEFERRED TAX ASSETS), AND THE TRANSACTION OR THOSE BENEFITS MAY TAKE LONGER TO REALIZE THAN EXPECTED.” · word for word
Elevated leverage and interest expense
“FINANCING THE TRANSACTION RESULTED IN AN INCREASE IN OUR INDEBTEDNESS, WHICH COULD ADVERSELY AFFECT US, INCLUDING BY DECREASING OUR BUSINESS FLEXIBILITY AND INCREASING OUR INTEREST EXPENSE.” · word for word
Organic growth deceleration
“Organic Revenue growth rate (2) 3.5 % 9.5 %” · word for word
27 Oct 20258-K · 2.02Total Revenues $1.61B (+35% y/y); Organic Revenue Growth 3.5; Diluted Net Income Per Share - Adjusted $1.05 (+15% y/y)earningsopen
Figures in the filing · each found in the filing text
| Total Revenues · Q3-2025 | $1.61B | +35% y/y |
| Organic Revenue Growth · Q3-2025 | 3.5% | |
| Diluted Net Income Per Share - Adjusted · Q3-2025 | $1.05 | +15% y/y |
| EBITDAC - Adjusted · Q3-2025 | $587M | +42% y/y |
| EBITDAC Margin - Adjusted · Q3-2025 | 36.6% |
Risks flagged
GAAP net income and EPS declined due to acquisition-related costs and amortization.
“Net income $227M (-3.0% YoY); diluted EPS $0.68 (-16.0% YoY); acquisition/integration costs $50M.”
Brown & Brown, Inc. — questions
- What did Brown & Brown, Inc. file recently?
- 17 SEC filings in the last 12 months. Latest: 8-K on 2026-10-22 — Director Bronislaw E. Masojada resigns from board and committees due to election as Lord Mayor of London; no disagreement with company.
Every figure on this page comes from Brown & Brown, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.